Drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor and preparation method thereof

Abstract

The invention relates to a drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor and a preparation method thereof. The traditional drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor has incomplete absorption, low bioavailability and slow curative effect. The drug comprises seven types of traditional Chinese medicines, such as radix polygonum multiflorum preparata, glossy privet fruit, mulberry, yerbadetajo herb, white paeony root, raidx astragali and rhizoma cibotii. In the invention, the yerbadetajo herb is monarch drug, the glossy privet fruit and the mulberry have the effect of strengthening the nourishing of the liver and kidney of the monarch drug, and are ministerial drugs in the formula, and the raidx astragali is adjuvant drug and is matched with the monarch drug and the ministerial drugs to enhance the treating effect; the radix polygonum multiflorum preparata, the white paeony root and the rhizoma cibotii are used for assisting the monarch drug and the ministerial drugs to strengthen the treatment of syndrome of the deficiency of yin and blood. The whole formula has the effects of nourishing the liver and the kidney and benefiting vital energy and blood, are used for treating the symptoms such as leukopenia, mental fatigue and acratia, fatigue and weakness of waist and knee, dizziness and tinnitus, palpitation, shortness of breath, agrypnia, dryness of the throat, bad food intake and little eating and the like.

Description

Technical field: [0001] The invention relates to a medicine for treating leukopenia caused by radiotherapy and chemotherapy of malignant tumors and a preparation method thereof. The medicine has the effects of nourishing the liver and kidney and replenishing qi and blood, and is used for leukopenia and fatigue caused by radiotherapy and chemotherapy of malignant tumors. , Weak waist and knees, dizziness, tinnitus, palpitations, shortness of breath, insomnia, dry throat, anorexia and lack of food embolism. technical background: [0002] It is a classic Chinese patent medicine for the treatment of leukopenia caused by radiotherapy and chemotherapy of malignant tumors. It is used for leukopenia, mental fatigue, weak waist and knees, dizziness, tinnitus, palpitations, shortness of breath, insomnia, dry throat, poor appetite and other diseases caused by chemotherapy and radiotherapy of malignant tumors. However, the traditional treatment of leukopenia caused by radiotherapy and ...

AI Technical Summary

Problems solved by technology

However, the traditional treatment of leukopenia caused by radiotherapy and chemotherapy for malignant tumors has incomplete absorption, low bioavailability, and slow curative effect.